Saturday, 19 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14435
Articles
Company
Merck & Co. Posts 22% YOY Sales Growth; Keytruda and Gardasil Drive Revenues
January 20, 2025
Company
Takeda Posts Strong Q3 Results, Announces Pipeline Advances in Oncology and Rare Diseases
January 20, 2025
Company
Drug
GenScript’s CAR-T Therapy Carvykti Achieves $55M in Sales, Awaits China Approval
January 20, 2025
Company
Deals
Zhejiang Gongdong to Acquire Trademark Plastics for Overseas Expansion
January 20, 2025
Company
Innovent Biologics Posts Strong Q4 Revenues Amid COVID-19 Challenges
January 20, 2025
Company
Deals
Shanghai Weimu Medical Raises Pre-Series A+ Funding for Clinical Development
January 20, 2025
Company
Deals
MicroPort Endovascular Plans RMB 2.55 Billion Private Placement
January 20, 2025
Company
Drug
OcuMension’s Phase I Study for Dry Eye Treatment OT-202 Concludes
January 20, 2025
Company
Eli Lilly Reports Q4 Financials with COVID-19 Impact and Market Performers
January 20, 2025
Company
Deals
Virpax Pharmaceuticals Seeks China Licensing Partner for Non-Opioid Pain Drug Envelta
January 20, 2025
Company
Novo Nordisk Posts Strong 2022 Results; GLP-1 Therapies Drive Growth
January 20, 2025
Company
Drug
Antengene Launches Phase I CLINCH Study for ATG-022 in Australia
January 20, 2025
1
2
…
1,038
1,039
1,040
1,041
1,042
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?